Display Settings:

Format

Send to:

Choose Destination
F1000 Biol Rep. 2009 Sep 28;1:73. doi: 10.3410/B1-73.

Customized care 2020: how medical sequencing and network biology will enable personalized medicine.

Author information

  • 1Department of Pathology, Beth Israel Deaconess Medical Center and Center for Biomedical Informatics, Harvard Medical School, 10 Shattuck St, Boston, MA 02115, USA. mark_boguski@hms.harvard.edu

Abstract

Applications of next-generation nucleic acid sequencing technologies will lead to the development of precision diagnostics that will, in turn, be a major technology enabler of precision medicine. Terabyte-scale, multidimensional data sets derived using these technologies will be used to reverse engineer the specific disease networks that underlie individual patients' conditions. Modeling and simulation of these networks in the presence of virtual drugs, and combinations of drugs, will identify the most efficacious therapy for precision medicine and customized care. In coming years the practice of medicine will routinely employ network biology analytics supported by high-performance supercomputing.

PMID:
20948615
[PubMed]
PMCID:
PMC2948270
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1.
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Faculty of 1000 Icon for PubMed Central
    Loading ...
    Write to the Help Desk